CTRI/2020/05/025370
Not yet recruiting
未知
Evaluation of Efficacy and Safety of Ayurveda Intervention (Guduchi Ghan Vati) in the management of COVID-19 infection (Asymptomatic & Mild symptoms)- An open label single arm prospective clinical trial.
Dr SR Rajasthan Ayurved University Jodhpur0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr SR Rajasthan Ayurved University Jodhpur
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.All hospitalized cases above 18\-60 years of age, clinically diagnosed with corona virus disease 2019 (Covid19\) and who are asymptomatic or having Mild symptoms.
- •2\.Participants who can take medicines orally.
- •3\.Patients willing to provide signed informed consent.
Exclusion Criteria
- •1\.Cases of severe vomiting which would affect oral administration of medicine difficult.
- •2\.Cases of respiratory failure and requiring mechanical ventilation.
- •3\.Patients having Alanine Transaminase (ALT) or Aspartate Transaminase (AST) \> 5 times the upper range of normal limits.
- •4\.Patients with COVID\-19 in critical condition or ARDS or NIAD 8 â??point ordinal score\-2 (Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
- •5\.Combined organ failure requiring ICU monitoring.
- •6\.Patients with uncontrolled Diabetes Mellitus, (HbA1c more than 8\.0\), Malignant Hypertension (systolic BP more than 180 and diastolic 110\), Chronic Renal Failure and those on immunosuppressive medication.
- •7\.Patients with history of malignancy, IHD, CAD, triple vessel disease, history of CABG, Stroke, etc.
- •8\.Any other condition, which as per the investigator would jeopardize the outcome of the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
Completed
Phase 2
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptomsCTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
Not yet recruiting
Phase 2
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19CTRI/2020/06/026002ational Institute of Ayurveda
Not yet recruiting
Not Applicable
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiotaCTRI/2020/10/028746AMRIT GODBOLE
Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80